LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-2.06%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.18B
AUM Growth
+$1.18B
(-0.2%)
Cap. Flow
+$15.5M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
24.05%
Holding
357
New
34
Increased
31
Reduced
193
Closed
83
Top Buys
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$35.8M |
| 2 |
iShares Russell 2000 Growth ETF
IWO
|
$33.7M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
$29.3M |
| 4 |
Pfizer
PFE
|
$17.4M |
| 5 |
Globe Life
GL
|
$9.97M |
Top Sells
| 1 |
Visa
V
|
$14.5M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$12M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
$10.6M |
| 4 |
BioNTech
BNTX
|
$10.1M |
| 5 |
Republic Services
RSG
|
$5.59M |
Sector Composition
| 1 | Healthcare | 41.98% |
| 2 | Financials | 15.26% |
| 3 | Consumer Discretionary | 12.3% |
| 4 | Technology | 7.74% |
| 5 | Industrials | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
26
DELISTED
LHC Group LLC
LHCG
| $16.4M | 1.39% |
100,000
-65,000
| -39% | -$10.6M |
|
27
Medifast
MED
$154M
| $16.3M | 1.38% |
150,000
| – | – |
|
28
Keysight
KEYS
$28.1B
| $16.1M | 1.36% |
102,173
-22,679
| -18% | -$3.57M |
|
29
Halozyme
HALO
$8.56B
| $15.7M | 1.33% |
396,617
-24,786
| -6% | -$980K |
|
30
Labcorp
LH
$23.1B
| $15.4M | 1.3% |
75,000
-5,716
| -7% | -$1.17M |
|
31
Abbott
ABT
$231B
| $15.3M | 1.3% |
157,885
-10,892
| -6% | -$1.05M |
|
32
Equity Lifestyle Properties
ELS
$11.7B
| $14.1M | 1.2% |
225,000
-25,000
| -10% | -$1.57M |
|
33
Baxter International
BAX
$12.7B
| $14M | 1.19% |
260,000
-2,100
| -0.8% | -$113K |
|
34
Microsoft
MSFT
$3.77T
| $12.9M | 1.09% |
55,429
+474
| +0.9% | +$110K |
|
|
SGFY
35
DELISTED
Signify Health, Inc.
SGFY
| $11.6M | 0.99% |
398,561
-103,886
| -21% | -$3.03M |
|
|
RCM
36
DELISTED
R1 RCM Inc. Common Stock
RCM
| $11.6M | 0.98% |
623,461
-45,336
| -7% | -$840K |
|
|
MDRX
37
DELISTED
Veradigm Inc. Common Stock
MDRX
| $11.3M | 0.95% |
738,973
-53,616
| -7% | -$817K |
|
38
Chemed
CHE
$6.67B
| $10.9M | 0.93% |
25,000
| – | – |
|
39
United Therapeutics
UTHR
$13.8B
| $10M | 0.85% |
47,794
-18,297
| -28% | -$3.83M |
|
|
40
Globe Life
GL
$11.3B
| $9.97M | 0.85% |
+100,000
| New | +$9.97M |
|
41
Glaukos
GKOS
$5.5B
| $9.01M | 0.76% |
169,255
+21,513
| +15% | +$1.15M |
|
|
42
BioNTech
BNTX
$24B
| $8.93M | 0.76% |
66,174
-74,784
| -53% | -$10.1M |
|
43
Apellis Pharmaceuticals
APLS
$3.48B
| $8.85M | 0.75% |
129,577
-65,549
| -34% | -$4.48M |
|
44
Option Care Health
OPCH
$4.65B
| $8.65M | 0.73% |
+275,000
| New | +$8.65M |
|
|
SWAV
45
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $8.54M | 0.72% |
30,702
-43,152
| -58% | -$12M |
|
46
Virtus Investment Partners
VRTS
$1.36B
| $7.98M | 0.68% |
50,000
| – | – |
|
47
iShares MSCI EAFE Growth ETF
EFG
$13.1B
| $7.35M | 0.62% |
+101,300
| New | +$7.35M |
|
48
Tandem Diabetes Care
TNDM
$845M
| $7.3M | 0.62% |
152,631
-34,046
| -18% | -$1.63M |
|
49
Alnylam Pharmaceuticals
ALNY
$58.5B
| $7.13M | 0.6% |
35,613
-10,491
| -23% | -$2.1M |
|
50
Tesla
TSLA
$1.08T
| $7.04M | 0.6% |
26,535
+19,134
| +259% | +$5.07M |
|